Amongst people with diseases other than RA, a number of patient groups showed a trend towards increased tenascin-C levels compared to healthy controls; none reached statistical significance although patient numbers were small for some diseases precluding any meaningful analysis between individual disease states. This evidence concerns the gene TNC and rheumatoid arthritis.